Clinical Trial Update: Phase IIB Pilot of Atazanavir + Raltegravir [Phase 2]

View source ↗

Summary

A Phase II trial evaluating the combination of atazanavir and raltegravir for HIV infection was terminated. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV | Phase 2 | Status: TERMINATED | Results posted: 2012-01-16